Duramune max 5/4L - Boehringer Ingelheim Vetmedica

For subcutaneous vaccination of healthy dogs 6 weeks ofage or older as an aid in the prevention of disease causedby canine distemper, infectious canine hepatitis, canineadenovirus type 2, canine parainfluenza and canineparvovirus.Directions for Use• General Directions: Aseptically rehydrate DuramuneMax 5 with Sterile Diluent supplied. Administer one1mLdosesubcutaneously.•PrimaryVaccination:A recommended vaccinationschedule should start at or about 6 weeks of age.Thepresence of maternal antibody is known to interferewith the development of active immunity. Puppiesshould be revaccinated every 2 to 3 weeks until12 weeks of age.All dogs over 12 weeks of age should initially receiveone dose of Duramune Max 5 and a second dose 2 to3 weeks later.•AnnualVaccination:Annual revaccination with onedose is recommended.Caution: Store in the dark at 2° to 7°C (35° to 45°F).AVOID FREEZING. SHAKE WELL. In case of anaphylactoidreaction, administer epinephrine. Burn container and allunused contents.Canine Distemper-AdenovirusType 2-Parainfluenza-Parvovirus VaccineModified Live VirusDuramune® Max 5For Veterinary Use Only25 Doses25 Vials of Vaccineplus 25 x 1 mL Vials of DiluentGentamicin added as preservative.Caution: In the absence of a veterinarian-client-patientrelationship, Federal law prohibits the relabeling,repackaging, resale, or redistribution of the individualcontents of this package.Ver las instrucciones completas al reverso.Duramune® is a registered trademark of BoehringerIngelheim Vetmedica, Inc.©2011BoehringerIngelheimVetmedica,Inc.AllRightsReserved. ReservadosTodos los Derechos.Boehringer Ingelheim Vetmedica, Inc.St. Joseph, MO 64506 U.S.A./EE.UU.U.S. Veterinary License No. 124Licencia Veterinaria de EE.UU. N° 124abcdThe PEEL-OFF LABEL I.D. SYSTEMprovides a simple and effective methodof recording pertinent information onthe vaccines administered to animals inaveterinarypractice.For vaccines requiring reconstitution,remove label from both vials and affixboth labels to the animal’s medicalchart.Using theSystem:1. Grasp the vial label atthe corner marked withan indicator arrow,between your thumband forefinger(figure 1).2. Pull steadily at a slightangle until the label isseparated from the vial(figure 2).3. Place the label on theanimal’s medical chart.Press down on the labelto ensure adhesion.(fig. 1)(fig. 2)El SISTEMA DE IDENTIFICACIÓN CONETIQUETA DESPEGABLE proporciona unmétodo sencillo y efectivo de registrar lainformación pertinente sobre lasvacunas administradas a los animalesen la práctica veterinaria.Para las vacunas que requierenreconstitución, quitar la etiqueta deambos frascos y adherirlas al registromédico del animal.Uso del Sistema:1. En la esquina marcadacon una flechaindicadora, tomar laetiqueta del frasco entreel pulgar y el índice(figura 1).2. Desprender tirandofirmemente en un pocode ángulo hasta que laetiqueta quedeseparada del frasco(figura 2).3. Colocar la etiqueta en elregistro médico delanimal. Presionar sobrela misma para asegurarsu adhesión.(fig. 1)(fig. 2)Vacuna contra Moquillo Canino-AdenovirusTipo 2-Parainfluenza-ParvovirusVirus Vivos ModificadosDuramune® Max 5Uso Veterinario25 DosisVacuna: 25 Frascosmás Diluyente: 25 Frascos de 1 mLPara la vacunación por vía subcutánea deperros sanos de 6 semanas de edad omayores como ayuda en la prevención deenfermedades causadas por moquillocanino, hepatitis canina infecciosa,adenovirus canino tipo 2, parainfluenzacanina y parvovirus canino.Indicaciones•InstruccionesGenerales:RehidratarDuramune Max 5 asépticamente con eldiluyente estéril suministrado. Administraruna dosis de 1 mL por vía subcutánea.•Primovacunación:Elprogramadevacunación recomendado debe empezar alas 6 semanas de edad aproximadamente.Se sabe que la presencia de anticuerposmaternos interfiere con el desarrollo de lainmunidad activa. Es necesario revacunaraloscachorroscada2a3semanashastaque tengan 12 semanas de edad.Todos los perros de más de 12 semanas deedad deben recibir una dosis inicial deDuramune Max 5 y una segunda dosis 2 a3semanasdespués.•VacunaciónAnual:Serecomiendalarevacunación anual con una sola dosis dela vacuna.Precaución: Almacenar en la oscuridad entre2° y 7°C (35° y 45°F). EVITAR LACONGELACIÓN. AGITAR BIEN. En caso dereacción anafilactoidea, administrarepinefrina. Incinerar el recipiente y todo elcontenido no utilizado.Contiene gentamicina como agenteconservante.Advertencia: En ausencia de una relaciónveterinario-cliente-paciente, la ley federal deEE.UU. prohibe el reetiquetado, reembalaje,reventa o redistribución del contenido deesta caja en forma individual.Duramune® es marca registrada deBoehringer Ingelheim Vetmedica, Inc.1Dose/1mLSterileDiluentTo be added asepticallyto vial of DESICCATEDVACCINE.See outer package forcomplete directions.Consultar la caja.Store at 2° to 7°C.Boehringer IngelheimVetmedica, Inc.St. Joseph, MO 64506U.S. Vet. Lic. No. 124Ser/ExpSer/Exp1DoseCanine Distemper-AdenovirusType 2-Parainfluenza-Parvovirus VaccineModified Live VirusDuramune® Max 5See outer package forcomplete directions.Consultar la caja.Store at 2° to 7°C.Boehringer IngelheimVetmedica, Inc.St. Joseph, MO 64506U.S. Vet. Lic. No. 124TD0901BD9161B

Proven safe, with enhanced purityDURAMUNE MAX 5/4L is safe, with a low incidence ofvaccine associated adverse events (VAAEs) demonstratedby the largest real-world safety study ever conducted oncanine vaccines. 1• Involved nearly 30,000 doses of DURAMUNE MAX 5/4Ladministered to dogs in real-world clinical settings• Fewer than three VAAEs per 1,000 dogs vaccinated withDURAMUNE MAX 5/4LA safe vaccine with a smooth injectionNo other lepto vaccine is made with our exclusive, technically advanced subunit purification processto deliver a “smooth” injection.Leptospira cellOuter cellmembraneOuter cellmembraneCellulardebrisOuter cellmembranedebrisSurfaceimmunogensImmunogens from all 4 serovarsSeparateOuter membranes aredetached from the restof the Leptospira cell.RemoveHeavier, potentiallyreactive cellulardebris is discarded.PurifyEssential surfaceimmunogens arefurther refinedthrough filtrationprocesses.BlendPotency-testedpurified immunogensfrom all four serovarsare combined.Boehringer Ingelheim Vetmedica, Inc.

Duramune Max 5/4L keeps dogs safeSafe from lepto• The first four-serovar vaccine to protect against today’s mostcommon lepto causes, grippotyphosa and pomona• 100 percent efficacious for spirochetemia against grippotyphosaand pomona by experimental challengeSafe from parvo• Proven protection from CPV-2b, the predominantCPV variant in the U.S. 2• The only parvo vaccine with proven efficacy against theemerging threat of CPV-2c through both challengeand cross-neutralization studies 2A proven track recordMore than 128 million lepto vaccine doses soldsince 1986 — more than any other manufacturer 2To be safe, a lepto vaccine must deliver effective protection fromall four of the serovars contained in DURAMUNE MAX 5/4L.A patient with incomplete protection is a real-life safety concern.D U R A M U N E M A X 5 / 4 L at a g l a n c e :• Four-serovar lepto vaccine• Proven safe in the largest real-world safety study ever on canine vaccines 1• The only lepto vaccine produced with a proprietary subunit purification processfor enhanced safety• Protects against today’s most common serovars, grippotyphosa and pomona• Parvo component protects against CPV-2b and 2c 2• More than 128 million lepto vaccine doses sold since 1986 2• Veterinarians’ number one choice for lepto protection 3• Five convenient combos and a stand-alone lepto vaccine• Backed by support from BIVI• Available from your favorite distributor partnerwww.BI-Vetmedica.comVisit LeptoInfo.com to learn more.1Moore GE, Guptill LF, Ward MP, et al. Adverse events diagnosed within three days of vaccine administration in dogs. JAVMA. 2005;227(7):1102-1108.2Data on file, Boehringer Ingelheim Vetmedica, Inc.3Canine & Feline Biologicals by OPC, Q2 2010. Animal Health Study Report. Market Dynamics, Inc Research and Consulting, 2010.©2010 Boehringer Ingelheim Vetmedica, Inc.All trademarks are property of their respective owners. CAN1110006